Advertisement

Sulfite oxidase deficiency – An unusual late and mild presentation

      Abstract

      Introduction: Sulfite oxidase deficiency (SOD) is an autosomal recessive inherited disease usually presenting in the neonatal period with severe neurological symptoms including seizures, often refractory to anticonvulsant therapy, and a rapidly progressive encephalopathy resembling neonatal hypoxic ischemia, with premature death. Most patients develop dislocated ocular lenses. Later or milder presentations of SOD are being reported with increasing frequency. These presentations include neurological regression with loss of previously acquired milestones or movement disorders. Case report: We report a four years old girl presenting with intermittent ataxia and uncoordinated limb movements. A similar episode of ataxia had occurred previously, one year before, with complete neurologic recovery and normal developmental milestones. Bilateral lens dislocation had been recently diagnosed. Cranial MRI demonstrated bilateral globus pallidus enhancement. Low homocysteine was found in plasma and SulfitestR was positive. Further investigations led to confirmation of isolated sulfite oxidase deficiency with no enzyme activity detected on skin fibroblasts culture. Discussion: This case illustrates the clinical variability of SOD and it is not only atypical but also seems to be the mildest form described so far. The association of ectopia lentis with a movement disorder, even without psychomotor regression, should prompt us to look for this diagnosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Johnson J.L.
        • Duran M.
        Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency.
        in: Scriver C.R. Beaudet A.L. Valle D. Sly W.S. Childs B. Kinzler K.W. The metabolic and molecular bases of inherited disease 8th ed. McGraw-Hill, New York2001: 3163-3177
        • Tan W.H.
        • Eichler F.S.
        • Hoda S.
        • Lee M.S.
        • Baris H.
        • Hanley C.A.
        • et al.
        Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature.
        Pediatrics. 2005; 116: 757-766
        • Sass J.O.
        • Gunduz A.
        • Funayama C.A.R.
        • Korkmaz B.
        • Pinto K.G.D.
        • Tuysuz B.
        • et al.
        Functional deficiencies of sulfite oxidase: differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia.
        Brain Dev. 2010; 32: 544-549
        • Zhang X.
        • Vincent A.S.
        • Halliwell B.
        • Wong K.P.
        A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase.
        J Biol Chem. 2004; 279: 43035-43045
        • Shih V.E.
        • Abroms I.F.
        • Johnson J.L.
        • Carney M.
        • Mandell R.
        • Robb R.M.
        • et al.
        Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism.
        N Engl J Med. 1977; 297: 1022-1028
        • Barbot C.
        • Martins E.
        • Vilarinho L.
        • Dorche C.
        • Cardoso M.L.
        A mild form of infantile sulfite oxidase deficiency.
        Neuropediatrics. 1995; 26: 322-324
        • Touati G.
        • Rusthoven E.
        • Depondt E.
        • Dorche C.
        • Duran M.
        • Heron B.
        • et al.
        Dietary therapy in two patients with a mild form of sulfite oxidase deficiency. Evidence for clinical and biological improvement.
        J Inher Metab Dis. 2000; 23: 45-53
        • Graf W.D.
        • Oleinik O.E.
        • Jack R.M.
        • Weiss A.H.
        • Johnson J.L.
        Ahomocysteinemia in molybdenum cofactor deficiency.
        Neurology. 1998; 51: 860-862
        • Sass J.O.
        • Nakanishi T.
        • Sato T.
        • Shimizu A.
        New approaches towards laboratory diagnosis of isolated sulphite oxidase deficiency.
        Ann Clin Biochem. 2004; 41: 157-159
        • Bindu P.S.
        • Christopher R.
        • Mahadevan A.
        • Bharath R.D.
        Clinical and imaging observations in isolated sulfite oxidase deficiency.
        J Child Neurol. 2011; 26: 1036-1040
        • Hoffmann C.
        • Ben-Zeev B.
        • Anikster Y.
        • Nissenkorn A.
        • Brand N.
        • Kuint J.
        • et al.
        Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency.
        J Child Neurol. 2007; 22: 1214-1221